Clinical Trials Logo

Transient Cerebrovascular Events clinical trials

View clinical trials related to Transient Cerebrovascular Events.

Filter by:
  • Completed  
  • Page 1

NCT ID: NCT02014896 Completed - Atrial Fibrillation Clinical Trials

Ischemia Care Biomarkers of Acute Stroke Etiology (BASE)

BASE
Start date: December 2013
Phase:
Study type: Observational

The proposed study will validate the clinical use of new biomarker blood tests to identify blood components that may differentiate between diverse stroke etiologies and clinical outcomes as listed below: 1. Differentiate between cardioembolic and large artery atherosclerotic ischemic strokes, when hemorrhagic stroke is ruled out. 2. In cases of ischemic strokes of unknown or "cryptogenic" etiology, determine the ability of biomarker blood tests to predict etiology between cardioembolic and large artery atherosclerotic. 3. In cases of cardioembolic ischemic stroke, further differentiation of cardioembolic ischemic strokes into those caused by atrial fibrillation (AF) and those not caused by AF. 4. Differentiate "transient ischemic attacks" (TIAs) from acute ischemic strokes. 5. Differentiate TIAs from non-ischemic "transient neurological events" (TNE) with similar symptoms.